Andrea Anichini

Andrea Anichini

UNVERIFIED PROFILE

Are you Andrea Anichini?   Register this Author

Register author
Andrea Anichini

Andrea Anichini

Publications by authors named "Andrea Anichini"

Are you Andrea Anichini?   Register this Author

76Publications

1728Reads

32Profile Views

A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy.

Front Immunol 2019 25;10:2514. Epub 2019 Oct 25.

Biomarkers Unit, Department of Applied Research and Technical Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fimmu.2019.02514DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823250PMC
October 2019

Progress in Understanding Complexity and Determinants of Immune-Related Prognostic Subsets in Primary Melanoma.

Authors:
Andrea Anichini

Cancer Res 2019 05;79(10):2457-2459

Human Tumors Immunobiology Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-19-0786DOI Listing
May 2019

Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Target Oncol 2018 10;13(5):567-582

Department of Medical Oncology Unit-1, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano and ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-018-0585-yDOI Listing
October 2018

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study.

J Clin Oncol 2018 Oct 20:JCO1801148. Epub 2018 Oct 20.

Andrea Necchi, Andrea Anichini, Daniele Raggi, Simona Massa, Maurizio Colecchia, Patrizia Giannatempo, Roberta Mortarini, Elena Farè, Francesco Monopoli, Antonella Messina, Roberto Salvioni, and Luigi Mariani, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori; Alberto Briganti, Roberta Lucianò, Marco Bianchi, Renzo Colombo, Andrea Gallina, Andrea Salonia, and Francesco Montorsi, Vita Salute San Raffaele University and Urological Research Institute, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele Hospital, Milan, Italy; Siraj M. Ali, Russell Madison, Jeffrey S. Ross, and Jon H. Chung, Foundation Medicine, Cambridge, MA; and Jeffrey S. Ross, Upstate Medical University, Syracuse, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.18.01148
Publisher Site
http://dx.doi.org/10.1200/JCO.18.01148DOI Listing
October 2018

The non-small cell lung cancer immune landscape: emerging complexity, prognostic relevance and prospective significance in the context of immunotherapy.

Cancer Immunol Immunother 2018 06 7;67(6):1011-1022. Epub 2018 Mar 7.

Department of Research, Human Tumors Immunobiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-018-2147-7DOI Listing
June 2018

Of Chemoimmunotherapy Sequences and Delayed Disease-modifying Activity in Advanced Urothelial Carcinoma: Vetus Fit Novum.

Eur Urol 2018 02 28;73(2):153-155. Epub 2017 Sep 28.

Bladder Cancer Center, Dana Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838173077
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2017.09.012DOI Listing
February 2018

IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients.

Oncoimmunology 2017 7;6(2):e1261242. Epub 2016 Dec 7.

Tumor Immunology and Immunopathology Laboratory, Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Campus - Germaneto, Catanzaro, Italy; Department of Microbiology, Cell and Tumorbiology (MTC), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1261242DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353942PMC
December 2016

Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases.

Clin Cancer Res 2014 Nov 19;20(22):5641-51. Epub 2014 Sep 19.

Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy. Department of Pathophysiology and Transplantation, University of Milano, Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0770DOI Listing
November 2014

Towards combinatorial targeted therapy in melanoma: from pre-clinical evidence to clinical application (review).

Int J Oncol 2014 Sep 10;45(3):929-49. Epub 2014 Jun 10.

Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2014.2491DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121406PMC
September 2014

Prediction of survival in patients with thin melanoma: results from a multi-institution study.

J Clin Oncol 2014 Aug 7;32(23):2479-85. Epub 2014 Jul 7.

Andrea Maurichi, Rosalba Miceli, Tiziana Camerini, Luigi Mariani, Roberto Patuzzo, Roberta Ruggeri, Gianfranco Gallino, Elena Tolomio, Gabrina Tragni, Barbara Valeri, Andrea Anichini, Roberta Mortarini, Daniele Moglia, Mario Santinami, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori, Milan; Giovanni Pellacani, Sara Bassoli, Caterina Longo, University Hospital of Modena and Skin Cancer Unit IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia; Pietro Quaglino, University Hospital of Turin, Turin; Nicola Pimpinelli, Lorenzo Borgognoni, University Hospital of Florence and Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence, Italy; Daniele Bergamaschi, Catherine Harwood, Queen Mary University of London, London, United Kingdom; and Odysseas Zoras, University Hospital of Heraklion, Crete, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.2340DOI Listing
August 2014

NFATc2 is a potential therapeutic target in human melanoma.

J Invest Dermatol 2012 Nov 21;132(11):2652-60. Epub 2012 Jun 21.

Human Tumors Immunobiology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2012.179DOI Listing
November 2012

AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway.

Melanoma Res 2012 Oct;22(5):341-50

Unit of Immunobiology of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0b013e3283544929DOI Listing
October 2012

Microfluidic devices modulate tumor cell line susceptibility to NK cell recognition.

Small 2012 Sep 3;8(18):2886-94. Epub 2012 Jul 3.

BioNEM (Bio and Nano Engineering and Technology for Medicine) Laboratory, Department of Clinical and Experimental Medicine, University "Magna Graecia" of Catanzaro, Loc. Germaneto, 88100 Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/smll.201200160DOI Listing
September 2012

Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways.

Clin Cancer Res 2012 Jun 2;18(12):3316-27. Epub 2012 May 2.

Human Tumors Immunobiology Unit, Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Medical Oncology Unit 3, Department of Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3426233PMC
June 2012

Human cutaneous melanomas lacking MITF and melanocyte differentiation antigens express a functional Axl receptor kinase.

J Invest Dermatol 2011 Dec 28;131(12):2448-57. Epub 2011 Jul 28.

Unit of Immunobiology of Human Tumors, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/jid.2011.218DOI Listing
December 2011

T-cell activation and maturation at tumor site associated with objective response to ipilimumab in metastatic melanoma.

J Clin Oncol 2011 Nov 11;29(32):e783-8. Epub 2011 Oct 11.

Unit of Medical Oncology 2, Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.36.5957DOI Listing
November 2011

Pharmacological activation of p53 triggers anticancer innate immune response through induction of ULBP2.

Cell Cycle 2011 Oct 1;10(19):3346-58. Epub 2011 Oct 1.

Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.10.19.17630DOI Listing
October 2011

Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma.

Cancer Res 2010 Nov 21;70(21):8378-87. Epub 2010 Sep 21.

Human Tumors Immunobiology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-2028DOI Listing
November 2010

Impaired STAT phosphorylation in T cells from melanoma patients in response to IL-2: association with clinical stage.

Clin Cancer Res 2009 Jun 9;15(12):4085-94. Epub 2009 Jun 9.

Department of Experimental Oncology, Human Tumors Immunobiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-3323DOI Listing
June 2009

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.

Blood 2009 Jan 22;113(1):18-27. Epub 2008 Sep 22.

C. Gandini Medical Oncology, Bone Marrow Transplantation Unit, Fondazione Istituti di ricovero e Cura a Carattere Scientifico, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2008-06-165654DOI Listing
January 2009

Interleukin-12: biological properties and clinical application.

Clin Cancer Res 2007 Aug;13(16):4677-85

Medical Oncology Unit 2, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale per lo Studio e la Cura dei Tumori, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-0776DOI Listing
August 2007

Regulation of breast cancer response to chemotherapy by fibulin-1.

Cancer Res 2007 May;67(9):4271-7

Molecular Biology Unit, Department of Experimental Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-4162DOI Listing
May 2007

Unique tumor antigens: evidence for immune control of genome integrity and immunogenic targets for T cell-mediated patient-specific immunotherapy.

Clin Cancer Res 2006 Sep;12(17):5023-32

Human Tumor Immunobiology Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-2682DOI Listing
September 2006

T cell infiltration and prognosis in HCC patients.

J Hepatol 2006 Aug 15;45(2):178-81. Epub 2006 Jun 15.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2006.06.005DOI Listing
August 2006

Targeting heat shock proteins on cancer cells: selection, characterization, and cell-penetrating properties of a peptidic GRP78 ligand.

Biochemistry 2006 Aug;45(31):9434-44

The Skaggs Institute for Chemical Biology and Department of Chemistry, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi060264jDOI Listing
August 2006

APAF-1 signaling in human melanoma.

Cancer Lett 2006 Jul 10;238(2):168-79. Epub 2005 Aug 10.

Unit of Human Tumor Immunobiology, Dept. of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133, Milan, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03043835050059
Publisher Site
http://dx.doi.org/10.1016/j.canlet.2005.06.034DOI Listing
July 2006

Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity.

Cancer Res 2006 Jul;66(13):6503-11

Unit of Immunobiology of Human Tumors, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-05-4671DOI Listing
July 2006

Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients.

Cancer Res 2006 Jun;66(12):6405-11

Unit of Human Tumors Immunobiology and Department of Pathology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-0854DOI Listing
June 2006

Skewed T-cell differentiation in patients with indolent non-Hodgkin lymphoma reversed by ex vivo T-cell culture with gammac cytokines.

Blood 2006 Jan 8;107(2):602-9. Epub 2005 Sep 8.

Human Tumor Immunobiology Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-06-2234DOI Listing
January 2006

HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.

J Cell Physiol 2005 Oct;205(1):10-8

Molecular Targeting Unit, Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.20387DOI Listing
October 2005

Constitutive expression and costimulatory function of LIGHT/TNFSF14 on human melanoma cells and melanoma-derived microvesicles.

Cancer Res 2005 Apr;65(8):3428-36

Human Tumor Immunobiology Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-04-3239DOI Listing
April 2005

Immunogenicity without immunoselection: a mutant but functional antioxidant enzyme retained in a human metastatic melanoma and targeted by CD8(+) T cells with a memory phenotype.

Cancer Res 2005 Jan;65(2):632-40

Units of Immunobiology of Human Tumors, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, Milan, Italy.

View Article

Download full-text PDF

Source
January 2005

The paradox of T-cell-mediated antitumor immunity in spite of poor clinical outcome in human melanoma.

Cancer Immunol Immunother 2004 Oct 3;53(10):855-64. Epub 2004 Jun 3.

Human Tumor Immunobiology Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-004-0526-8DOI Listing
October 2004

Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.

Cancer Res 2004 Oct;64(20):7386-94

Human Tumor Immunobiology Unit, Department of Experimental Oncology and Department of Pathology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-04-1640DOI Listing
October 2004

Immunological and pathobiological roles of fibulin-1 in breast cancer.

Oncogene 2004 Mar;23(12):2153-60

Molecular Targeting Unit, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207323DOI Listing
March 2004

Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection.

Haematologica 2003 Dec;88(12):1396-404

C. Gandini Bone Marrow Transplantation Unit, Department of Medical Oncology, Istituto Nazionale Tumori, via Venezian 1, 20133 Milan, Italy.

View Article

Download full-text PDF

Source
December 2003

Immunotherapy of melanoma.

Semin Cancer Biol 2003 Dec;13(6):391-400

Istituto Nazionale per lo Studio e la Cura dei Tumori, Via G. Venezian, 1-20133 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semcancer.2003.09.001DOI Listing
December 2003

Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.

J Immunol 2003 Aug;171(4):2134-41

Human Tumor Immunobiology and Tumor Immunotherapy Units, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.171.4.2134DOI Listing
August 2003

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction.

Immunol Rev 2002 Oct;188:97-113

Units of Human Tumor Immunotherapy and Immunobiology, Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1034/j.1600-065x.2002.18809.xDOI Listing
October 2002

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

J Natl Cancer Inst 2002 Jun;94(11):805-18

Unit of Immunotherapy of Human Tumors, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/94.11.805DOI Listing
June 2002

T-cell response to unique and shared antigens and vaccination of cancer patients.

Cancer Immun 2002 Jun 28;2. Epub 2002 Jun 28.

Unit of Immunotherapy of Human Tumors, Department of Experimental Oncology, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
June 2002